2,3,3',4,4',5-Hexachlorobiphenyl


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
13112 CYP3A11 Increases expression PMID:17324954
1543 CYP1A1 Increases activity PMID:10986007; PMID:16750337; PMID:16750337; PMID:18493746
1543 CYP1A1 Increases expression PMID:15352264; PMID:25654323; PMID:15352264; PMID:25654323; PMID:29738842; PMID:16750337; PMID:23674508
1544 CYP1A2 Affects activity PMID:10986007; PMID:15659567
1544 CYP1A2 Increases expression PMID:23674508
1545 CYP1B1 Increases expression PMID:23674508; PMID:25654323; PMID:29738842
1584 CYP11B1 Increases expression PMID:16396990
1585 CYP11B2 Increases expression PMID:16396990
196 AHR Increases activity PMID:10448124; PMID:11339718; PMID:25654323; PMID:12850102; PMID:15352264; PMID:25654323
218 ALDH3A1 Increases expression PMID:29738842
25976 TIPARP Increases expression PMID:29738842
5594 MAPK1 Increases activity PMID:16293362
5595 MAPK3 Increases activity PMID:16293362
57491 AHRR Increases expression PMID:29738842
9970 NR1I3 Increases activity PMID:19746742

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.